Graves' disease and hyperthyroidism trials in Japan

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

  Where

  Bunkyo-ku, Iizuka, Kawasaki, Kitakyushu, Kyoto, Nagasaki, Okayama, Ōta-ku, Shibuya City, Yokohama, Yonago

  Age

  18 years and over

  People

  230 worldwide

  Run by

  argenx

  See details and how to joinNCT07596849 · EU 2025-523333-26-00
• Phase 2Taking people
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Kamogawa, Kitakyushu, Kumamoto, Kurume, Kyoto, Maebashi, Minokamo, Nagasaki, Nagoya, Nankoku, Shibuya City, Yokohama

  Age

  18 years to 75 years

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00